NSCEB at the 20th Annual Non-Dilutive Funding Summit
The 20th Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with representatives from some of the leading funding agencies including DARPA, CDMRP, ATI, NHLBI, NSCEB, NIA and more, giving attendees the opportunity to learn more in-depth about what non-dilutive funding opportunities are available and relevant for their R&D directly from the funding agencies.
Additionally, the 2024 FreeMind Elite honorees took to the stage to present about their companies research and pipelines and their journey to securing non-dilutive funding.
This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences.
National Security Commission on Emerging Biotechnology
The National Security Commission on Emerging Biotechnology (NSC-EB) was established in 2021 by the U.S. Congress to assess the national security implications of advances in biotechnology. The commission’s purpose is to evaluate how emerging biotechnologies, such as gene editing, synthetic biology, and bioengineering, could impact national security, defense capabilities, public health, and global stability. It provides recommendations on how the U.S. can maintain leadership in biotechnological innovation while managing risks related to biosecurity, bioethics, and the potential for misuse of these technologies. The final report, delivered in 2023, emphasized the need for strategic investments, stronger regulatory frameworks, and international collaboration to address both the opportunities and challenges posed by biotechnology.
Joe Buccina, Director of Policy and Research
Joe is a mission-focused professional, with 15+ years of experience working at the intersection of biotech and national security. His areas of expertise include biotechnology, biodefense, bioinformatics/computational biology, AIxBio, and national security. Joe has leadership experience in technology startups, venture capital, the federal government, and management consulting. He has an MS in Bioinformatics from Johns Hopkins University and MS in International Relations / International Economics from Johns Hopkins SAIS.
